BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17123805)

  • 1. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
    Hesse M; Fröhlich LF; Zeitz U; Lanske B; Erben RG
    Matrix Biol; 2007 Mar; 26(2):75-84. PubMed ID: 17123805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
    Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
    J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo.
    Anour R; Andrukhova O; Ritter E; Zeitz U; Erben RG
    PLoS One; 2012; 7(2):e31376. PubMed ID: 22319626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of vitamin D in sulfate homeostasis: regulation of the sodium-sulfate cotransporter by 1,25-dihydroxyvitamin D3.
    Bolt MJ; Liu W; Qiao G; Kong J; Zheng W; Krausz T; Cs-Szabo G; Sitrin MD; Li YC
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E744-9. PubMed ID: 15165995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
    Streicher C; Zeitz U; Andrukhova O; Rupprecht A; Pohl E; Larsson TE; Windisch W; Lanske B; Erben RG
    Endocrinology; 2012 Apr; 153(4):1795-805. PubMed ID: 22294750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
    Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
    J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice.
    Kovacs CS; Woodland ML; Fudge NJ; Friel JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E133-44. PubMed ID: 15741244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
    Andrukhova O; Streicher C; Zeitz U; Erben RG
    Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
    Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
    J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gene expression profile in the kidney of vitamin D receptor knockout mice.
    Li X; Zheng W; Li YC
    J Cell Biochem; 2003 Jul; 89(4):709-19. PubMed ID: 12858337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice.
    Razzaque MS; Lanske B
    Trends Mol Med; 2006 Jul; 12(7):298-305. PubMed ID: 16731043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation among hyperphosphatemia, type II sodium phosphate transporter activity, and vitamin D metabolism in Fgf-23 null mice.
    Sitara D
    Ann N Y Acad Sci; 2007 Nov; 1116():485-93. PubMed ID: 17646263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
    Kurosu H; Kuro-O M
    Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
    Shimada T; Yamazaki Y; Takahashi M; Hasegawa H; Urakawa I; Oshima T; Ono K; Kakitani M; Tomizuka K; Fujita T; Fukumoto S; Yamashita T
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1088-95. PubMed ID: 15998839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism.
    Weber K; Bergow C; Hirmer S; Schüler C; Erben RG
    J Bone Miner Res; 2009 Jan; 24(1):22-32. PubMed ID: 18767932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition.
    Tanaka H; Seino Y
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):343-5. PubMed ID: 15225798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.